公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial | Yuan J.; Mo B.; Ma Z.; Lv Y.; Cheng S.-L.; Yang Y.; Tong Z.; Wu R.; Sun S.; Cao Z.; Wu J.; Zhu D.; Chang L.; Zhang Y.; Zhao L.; Wang X.; Wang X.; Wang D.; Li X.; Peng Y.; Liang Y.; Liu H.; Xiao Z.; Lv X.; Wu S.; Dai Y.; Huang Y.; Hu Z.; Qiu C.; Li X.; Zhang S.; Li W.; Liu S.; Shi Y.; Xiong C.; Kuang J.; Xiu Q.; Cui S.; Li J.; Lin Q.; Huang W.; Wan Y.; Qimanguli, Shen C.; Xiao Y.; Wu X.; Chuang Y.C.; Perng W.C.; Tsao S.-M.; Hsu J.-Y.; Wang C.-C.; Wang J.-H.; Yeh P.-F.; Lin H.-H.; PING-HUNG KUO ; Lin M.-S.; Su W.-J.; Investigator Group of the Phase 3 Study on Oral Nemonoxacin | Journal of Microbiology, Immunology and Infection | 28 | 26 | |
2008 | Transcription factor SOX-5 enhances nasopharyngeal carcinoma progression by down-regulating SPARC gene expression | Huang D.-Y.; YU-TSAN LIN ; Jan P.-S.; Hwang Y.-C.; Liang S.-T.; Peng Y.; Huang C.-Y.F.; Wu H.-C.; CHIN-TARNG LIN | Journal of Pathology | 48 | 47 | |
2021 | Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern | Skelly D.T.; Harding A.C.; Gilbert-Jaramillo J.; Knight M.L.; Longet S.; Brown A.; Adele S.; Adland E.; Brown H.; Chinnakannan S.; Donnison T.; Ali M.; Rongkard P.; Pace M.; Zacharopoulou P.; Robinson N.; Csala A.; De Lara C.; Hutchings C.L.; Mehta H.; Lee L.N.; Edmans M.; Hackstein C.-P.; Phalora P.; Li W.; Phillips E.; Malone T.; Ogbe A.; Jay C.; Tipoe T.; Tipton T.; Stafford L.; Mentzer A.J.; Johnson S.A.; Amini A.; Marjot T.; Dimitriadis S.; Simmons B.; Deeks A.; Kerneis S.; Abuelgasim H.; Wilson R.; Thomas S.R.; Watson A.; Alhussni A.; Cutteridge J.; Weeks E.; Denly L.; Lillie K.; Holmes J.; Matthews P.C.; O'Donnell D.; Tan T.K.; Schimanski L.; Kuan-Ying A. Huang ; Rijal P.; Turtle L.; de Silva T.; Richter A.; Duncan C.J.A.; Payne R.P.; Moore S.C.; Knight J.C.; Cassar M.P.; Raman B.; Neubauer S.; Fries A.; Talbot N.P.; Petousi N.; Ho L.-P.; Peng Y.; Dong T.; Camara S.; Marinou S.; Linder A.; Adlou S.; Kasanyinga M.; Bridges-Webb A.; Hill J.; Silva-Reyes L.; Blackwell L.; Frater J.; Goulder P.; Conlon C.P.; Jeffery K.; Dold C.; Pollard A.J.; Sigal A.; de Oliveira T.; Townsend A.R.; Klenerman P.; Dunachie S.J.; Barnes E.; Carroll M.W.; James W.S.; Medawar Laboratory Team, OPTIC (Oxford Protective T cell Immunology for COVID-19) Clinical Group, PITCH (Protective Immunity T cells in Health Care Worker) Study Group, C-MORE/PHOSP-C Group | Nature Communications | 106 | 83 | |